Filters: Keyword is Narcotics [Clear All Filters]
"Burden of substance use disorders, mental illness, and correlates of infectious diseases among soon-to-be released prisoners in Azerbaijan." Drug and alcohol dependence 151 (2015): 68-75. Abstract
"Prevalence and experience of chronic pain in suburban drug injectors." Drug and alcohol dependence 151 (2015): 92-100. Abstract
"Within-prison drug injection among HIV-infected male prisoners in Indonesia: a highly constrained choice." Drug and alcohol dependence 149 (2015): 71-9. Abstract
"Investigation of the interactions between methadone and elvitegravir-cobicistat in subjects receiving chronic methadone maintenance." Antimicrobial agents and chemotherapy 57, no. 12 (2013): 6154-7. Abstract
"Counseling and directly observed medication for primary care buprenorphine maintenance: a pilot study." Journal of addiction medicine 6, no. 3 (2012): 205-11. Abstract
"Human immunodeficiency virus testing practices among buprenorphine-prescribing physicians." Journal of addiction medicine 6, no. 2 (2012): 159-65. Abstract
"Group-based strategies for stress reduction in methadone maintenance treatment: what do patients want?" Journal of addiction medicine 5, no. 3 (2011): 181-7. Abstract
"Epidemiologic trends and geographic patterns of fatal opioid intoxications in Connecticut, USA: 1997-2007." Drug and alcohol dependence 115, no. 3 (2011): 221-8. Abstract
"Oral substitution treatment of injecting opioid users for prevention of HIV infection." Cochrane database of systematic reviews (Online), no. 8 (2011): CD004145. Abstract
"Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs." Lancet 376, no. 9738 (2010): 367-87. Abstract
"Improved HIV and substance abuse treatment outcomes for released HIV-infected prisoners: the impact of buprenorphine treatment." Journal of urban health : bulletin of the New York Academy of Medicine 87, no. 4 (2010): 592-602. Abstract
"Commentary on Larney (2010): a call to action-opioid substitution therapy as a conduit to routine care and primary prevention of HIV transmission among opioid-dependent prisoners." Addiction (Abingdon, England) 105, no. 2 (2010): 224-5.
"Cost analysis of clinic and office-based treatment of opioid dependence: results with methadone and buprenorphine in clinically stable patients." Drug and alcohol dependence 99, no. 1-3 (2009): 132-40. Abstract
"Narrative review: buprenorphine for opioid-dependent patients in office practice." Annals of internal medicine 148, no. 9 (2008): 662-70. Abstract
"Substitution treatment of injecting opioid users for prevention of HIV infection." Cochrane database of systematic reviews (Online), no. 2 (2008): CD004145. Abstract
"Women and opioid dependence treatment: office-based versus opioid treatment program-based care?" Substance abuse : official publication of the Association for Medical Education and Research in Substance Abuse 28, no. 2 (2007): 3-8. Abstract
"Behavioral counseling content for optimizing the use of buprenorphine for treatment of opioid dependence in community-based settings: a review of the empirical evidence." The American journal of drug and alcohol abuse 33, no. 5 (2007): 643-54. Abstract
"Evaluation of a combined online and in person training in the use of buprenorphine." Substance abuse : official publication of the Association for Medical Education and Research in Substance Abuse 27, no. 3 (2006): 39-45. Abstract
"New challenges and opportunities in managing substance abuse in Malaysia." Drug and alcohol review 25, no. 5 (2006): 473-8. Abstract
"Training HIV physicians to prescribe buprenorphine for opioid dependence." Substance abuse : official publication of the Association for Medical Education and Research in Substance Abuse 27, no. 3 (2006): 13-8. Abstract
"Can home-made injectable opiates contribute to the HIV epidemic among injection drug users in the countries of the former Soviet Union?" Addiction (Abingdon, England) 101, no. 5 (2006): 731-7. Abstract
"Three case reports of a clinical pharmacokinetic interaction with buprenorphine and atazanavir plus ritonavir." AIDS (London, England) 20, no. 5 (2006): 783-4.
"Brief report: Methadone treatment of injecting opioid users for prevention of HIV infection." Journal of general internal medicine 21, no. 2 (2006): 193-5. Abstract
"Buprenorphine: its role in preventing HIV transmission and improving the care of HIV-infected patients with opioid dependence." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 41, no. 6 (2005): 891-6. Abstract
"Provider satisfaction with office-based treatment of opioid dependence: a systematic review." Substance abuse : official publication of the Association for Medical Education and Research in Substance Abuse 26, no. 1 (2005): 15-22. Abstract
"Decreasing international HIV transmission: the role of expanding access to opioid agonist therapies for injection drug users." Addiction (Abingdon, England) 100, no. 2 (2005): 150-8. Abstract
"Drug interactions between opioids and antiretroviral medications: interaction between methadone, LAAM, and nelfinavir." The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 13, no. 2 (2004): 163-80. Abstract
"Faculty development in small-group teaching skills associated with a training course on office-based treatment of opioid dependence." Substance abuse : official publication of the Association for Medical Education and Research in Substance Abuse 25, no. 4 (2004): 35-40. Abstract
"Buprenorphine for office-based practice: consensus conference overview." The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 13 Suppl 1 (2004): S1-7. Abstract
"Processes of care during a randomized trial of office-based treatment of opioid dependence in primary care." The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 13 Suppl 1 (2004): S67-78. Abstract
"The protease inhibitor lopinavir-ritonavir may produce opiate withdrawal in methadone-maintained patients." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 37, no. 4 (2003): 476-82. Abstract
"Methadone syrup injection in Australia: a sentinel finding?" Addiction (Abingdon, England) 98, no. 4 (2003): 385-6.
"Guideline development for office-based pharmacotherapies for opioid dependence." Journal of addictive diseases 22, no. 4 (2003): 109-20. Abstract
"A preliminary, controlled investigation of magnesium L-aspartate hydrochloride for illicit cocaine and opiate use in methadone-maintained patients." Journal of addictive diseases 22, no. 2 (2003): 49-61. Abstract
"The pharmacokinetics of methadone following co-administration with a lamivudine/zidovudine combination tablet in opiate-dependent subjects." The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 11, no. 1 (2002): 66-74. Abstract
"Utility of crossover designs in clinical trials: efficacy of desipramine vs. placebo in opioid-dependent cocaine abusers." The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 11, no. 2 (2002): 111-23. Abstract
"Clinical practice. Office-based treatment of opioid-dependent patients." The New England journal of medicine 347, no. 11 (2002): 817-23.
"New federal initiatives to enhance the medical treatment of opioid dependence." Annals of internal medicine 137, no. 8 (2002): 688-92. Abstract
"A staging system to predict prognosis among methadone maintenance patients, based on admission characteristics." Substance abuse : official publication of the Association for Medical Education and Research in Substance Abuse 23, no. 4 (2002): 233-44. Abstract
